Microdosing of GLP-1's The Rationale for Microdosing While GLP-1 receptor agonists (GLP-1 RAs) are effective treatments, higher doses can cause gastrointestinal side effects such as nausea and vomiting
Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines
The primary ones involve worsened side effects like nausea and a risk of hypoglycemia (low blood glucose levels), especially for those with diabetes
Arillotta D, Floresta G, Guirguis A, Corkery JM, Catalani V, Martinotti G, Sensi SL, Schifano F
As seen in Description Support Your Body While on Berberine Medications Like Ozempic, Wegovy, or Mounjaro Berberine medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have revolutionized the landscape of medical weight lossbut they can also put additional nutritional demands on your body
